rethinkPeptides Search
Menu
Study breakdown

Opening the Ring of Cyclotides: The Cystine Knot Forms Even Without the Circular Backbone

In VitroModerate evidence
The takeaway

Linear (ring-opened) versions of the cyclotide kalata B1 still fold into the characteristic cystine knot structure, but backbone cyclization is required for full biological activity and maximal stability.

Knot forms without ring

The cystine knot folds correctly even in linear versions, but the circular backbone adds the stability and activity needed for drug function

What the researchers found

Acyclic permutants of kalata B1 folded into native-like cystine knot structures without the circular backbone, but backbone cyclization was required for full biological activity and optimal structural stability.

Why it matters

For drug design, this means the cystine knot is a robust folding unit that could be used independently. But for maximum stability and activity, the full cyclic structure is needed.

How the study worked

In-vitro structural study using synthetic linear versions of kalata B1. NMR spectroscopy determined structures, thermal stability measured, and biological activity compared to native cyclotide.

What this study cannot tell us

Study on a single cyclotide (kalata B1). Other cyclotides may behave differently. Specific activity assays were limited.

How to read the evidence

Moderate evidence from a well-designed structural comparison using NMR and functional assays on native and engineered cyclotide variants.

When this study was published

Published in 2000. This structure-function dissection has guided cyclotide drug engineering approaches.

The bigger picture

This study separates the contributions of the two structural features of cyclotides: the cystine knot provides the basic fold, while cyclization provides the extra stability and activity needed for function.

Questions still open

  • Can partially stabilized linear versions serve as simpler drug scaffolds?
  • Does the cystine knot alone provide sufficient stability for oral drug delivery?
  • Can cyclization be achieved more easily during synthesis?

Common questions

Can cyclotides work without being circular?
Partially. The 3D structure forms even when the ring is opened, but full biological activity and maximum stability require the complete circular backbone. Both features contribute to cyclotide function.
What does this mean for making cyclotide drugs?
It means drug designers can use the cystine knot as a folding scaffold even in linear peptides, but for the best therapeutic properties, maintaining the full cyclic structure is preferred.

Read the original research

Acyclic permutants of naturally occurring cyclic proteins. Characterization of cystine knot and beta-sheet formation in the macrocyclic polypeptide kalata B1.

The Journal of biological chemistry, 275(25), 19068-75

Citation

Daly, N L; Craik, D J. (2000). Acyclic permutants of naturally occurring cyclic proteins. Characterization of cystine knot and beta-sheet formation in the macrocyclic polypeptide kalata B1.. The Journal of biological chemistry, 275(25), 19068-75.